Descriere

Cursuri postuniversitare:2013: Seminar instruire HIVERA privind scrierea de propuneri de proiecte, Iasi2013: Corticoterapia topica in practica curenta, Iasi2013: Arta…in terapia antiinfectioasa. Arta … si terapia antiinfectioasa, Iasi2012: Afectiuni dermatologice in practica curenta, Iasi2011: Update in Patologia infectioasa, Iasi2011: Terapia antivirala a hepatitelor la adult si copil – inovatie, motivatie, Bucuresti2011: Terapia intensiva in bolile infectioase ale anului 2011, Bucuresti2011: Hepatitele cronice virale, Iasi2011: Infectiile cu virusurile hepatitice – abord medical si bioetic, Attersee, Austria2011: Actualitati in dermatopatologie, Iasi2009: Sindromul metabolic – actualitati si controverse, Moinesti2009: Infectiile nosocomiale – o preocupare permanenta, dar subevaluata in practica medicala si chirurgicala - Moinesti2009: Elemente de biologie moleculara, genetica virala si diagnostic imunologic in bolile infectioase, Timisoara Carti publicate la edituri recunoscute CNCSIS:2014: Dorobat C, E. Miftode, Luca M. C. Infectious diseases Ed. „Gr. T. Popa” Iasi2014: Luca M. C., Dorobat C, Vata A. Tropical diseases, Ed. „Gr. T. Popa” Iasi2013: Vata A., Luca M.C., Dorobat C. Maladies tropicales. Ed. „Gr. T. Popa” Iasi2012: Dorobat C., Luca M/ C. et all Boli Infectioase diagnostic si tratament, Ed. “Gr. T. Popa” Iasi2012: Vata A., Luca M.C., Dorobat C. Boli tropicale. Ed. „Gr. T. Popa” Iasi2011: Carmen Dorobat, Egidia Miftode, Mihaela Catalina Luca,Carmen Manciuc, Daniela Leca,Mihnea Hurmuzache, Boli infectioase - curs pentru studenti si studii postuniversitare, Ed. Tehnopress2011: Mihaela Catalina Luca, Carmen Dorobat – TROPICAL DISEASES –for medical students, Ed. Tehnopress2007: Mihaela Catalina Luca - Curs de boli infectioase pentru studentii facultatilor de medicina, Ed. Tehnopress, Iasi, Editia a II-a.2003: Mihaela Catalina Luca 2003 - Curs de boli infectioase pentru studentii facultatilor de medicina, Ed. Tehnopress, Iasi, Editia ICapitole publicate in carti in format tiparit:2012: Azoicai D., Balan Gh., Caruntu I.D., Dumitriu C. et al. Modul integrativ pentru studiul ficatului, Ed. “Gr. T. Popa” Iasi Capitolul XVII. Carmen Mihaela Dorobat, Catalina Mihaela Luca, Carmen Manciuc, A.Vata, Laura Ghibu. Patologia infectioasa a ficatului2009: Mihaela Catalina Luca, Andrei Vata, Bogdan Constantin Moldoveanu: Hepatotoxicitatea rifampicinei in cursul terapiei meningitei tuberculoase, [NEW PATHOPHYSIOLOGICAL CHALLENGES AND PHARMACOLOGICAL APPROACHES], Ed. Junimea Iasi Catalina Mihaela Luca, Mihnea Hurmuzache, Andrei Vata, Denisa Covaciuc, Dragos Florea, Carmen Dorobat. [Factori predictivi pentru aparitia efectelor adverse hematologice la pacientii cu hepatita cronica C tratati cu Pegasys si Copegus]. Catalina Elena Lupusoru, Cristina Mihaela Ghiciuc, Liliana Taratu. [NEW PATHOPHYSIOLOGICAL CHALLENGES AND PHARMACOLOGICAL APPROACHES], Ed. Junimea IasiFarmacoterapia toxocarozei- posibile efecte adverse. Roxana- Gabriela Bahnea, Mariana Luca, Liliana Tartau, Carmen Ripa, Ingrid Cojocaru, Mihaela Catalina Luca: Farmacologia efectelor adverse in medicina. Ed. Junimea Iasi2009: Roxana Gabriela Bahnea, Mariana Luca, Liliana Tartau, Carmen Rapa, Ingrid Cojocaru, Mihaela Catalina Luca: Farmacoterapia toxocarozei – posibile efecte adverse), [NEW PATHOPHYSIOLOGICAL CHALLENGES AND PHARMACOLOGICAL APPROACHES] Ed. Junimea Iasi2003: Mihaela Catalina Luca, A. Teodor, Carmen Dorobat, Daniela Leca, Rodica, Fantanaru, Carmen Corcaci, D.Teodor, Tatiana Turcu. Studiu terapeutic asupra salmonelozei gastrointestinale. In: Chimioterapia antibacteriana, antifungica si antivirala actuala. Mihai Nechifor Ed. Casa cartii de stiinta, Cluj-Napoca Daniela Leca, D. Teodor, A. Ciobanu, Egidia Miftode, Catalina Luca, E. Danila, Andra Teodor. Fluorochinolonele în tratamentul endocarditelor bacteriene. In Chimioterapia antibacteriana, antifungics si antivirala actuala. Mihai Nechifor Ed. Casa cartii de stiinta, Cluj-Napoca Studii clinice:2013-2014: Subinvestigator in cadrul studiului Abbvie M13-774: A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333. Co-administered with and without Ribavirin Compared to Telaprevir. Co-administered with Pegylated Interferon α-2a and Ribavirin in Treatment-Naïve Adults with Chronic Hepatitis C Genotype 1 Virus Infection (MALACHITE I) 2013-2014: Subinvestigator in cadrul studiului Bristol-Myers Squibb AI452-030, A Phase 3. Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subject with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who are Prior Relapsers to Pegylated interferon alfa/RBV. Premii:2013: Premiul al II-lea in cadrul manifestarii Zilele Stiintifice ale Institutului National de Boli infectioase Prof. Dr. Matei Bals pt lucrarea Imported malaria in the Infectious Diseases Hospital of Iasi: epidemiologica land clinical characteristics of 28 consecutive cases. Autori: Andrei Vata, Daniela Leca, Mihaela Catalina Luca, Adina Colesniuc, Catalina Logigan, Denisa Covaciuc, Carmen Dorobat2009: mentiunea II: Conferinta Nationala de Boli infectioase Timisoara pentru lucrarea Factori predictivi pentru aparitia efectelor adverse hematologice la pacientii cu HVC tratati cu Pegasys si Copegus2008: Premiul al II-lea al celui de-al X-lea Congres National de Boli infectioase Cluj-Napoca pentru lucrarea Quantiferon-tb gold test (in serum and csf) and tuberculous meningis – a 25 patients study. Autori: Catalina Mihaela Luca, Andrei Vata, Cristina Mirela Petrovici, Eduard Nastase, Carmen Dorobat, Andra Teodor, Andrei Luca, Vasile Luca.